Back to results
US 11,686,720 B2Granted
Nanomechanical profiling of breast cancer molecular subtypes
AssigneeUniversitäT Basel
InventorsMarija Plodinec, Ellen Obermann, Philipp Oertle, Christian Räz
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for classifying a tissue sample obtained from mammary carcinoma. The method comprises determining a stiffness value for each of a plurality of points on said tissue sample, resulting in a stiffness distribution, and assigning said sample to a breast cancer subtype and nodal status based on said stiffness distribution.
Claims18
A method for classifying a tissue sample obtained from a mammary tumour, said method comprising
- determining a stiffness value for each of a plurality of points on said tissue sample using a device for determining stiffness values, resulting in a stiffness distribution, and
- assigning said sample to a breast cancer molecular subtype based on said stiffness distribution, wherein said breast cancer molecular subtype is selected from
- luminal A subtype non-metastasized breast cancer,
- luminal B subtype non-metastasized breast cancer,
- luminal A subtype metastasized breast cancer,
- luminal B subtype metastasized breast cancer,
- luminal B like Her2+ subtype metastasized breast cancer,
- basal subtype non-metastasized breast cancer, and
- basal subtype metastasized breast cancer,
- wherein
- a high probability of being a luminal A subtype non-metastasized breast cancer or a luminal B subtype non-metastasized breast cancer is assigned to a sample exhibiting only one frequency maximum between 0.4 kPa and 0.7 kPa in the region below 1 kPa and frequencies in the region between 1.0 kPa and 1.5 kPa, wherein said frequencies are above a threshold, and wherein said threshold equates to the half-maximal frequency of said one frequency maximum between 0.4 kPa and 0.7 kPa,
- a high probability of being a luminal A subtype metastasized breast cancer is assigned to a sample exhibiting two frequency maxima below 1 kPa and a frequency maximum above 2 kPa,
- a high probability of being a luminal B subtype metastasized breast cancer is assigned to a sample exhibiting a frequency maximum below 0.25 kPa, a high probability of being a luminal B Her2+ like subtype metastasized breast cancer is assigned to a sample exhibiting a frequency maximum between 0.25 kPa and 0.4 kPa and a frequency maximum between 1.7 kPa and 2.0 kPa,
- a high probability of being a basal subtype non-metastasized breast cancer is assigned to a sample exhibiting only one frequency maxima between 0.5 kPa and 0.7 kPa in the region below 1 kPa and frequencies in the region between 1.0 kPa and 1.5 kPa, wherein said frequencies are below a threshold, and wherein said threshold equates to the half-maximal frequency of said one frequency maximum between 0.5 kPa and 0.7 kPa,
- a high probability of being a basal subtype metastasized breast cancer is assigned to a sample exhibiting two frequency maxima below 1 kPa and that is further characterized by the absence of further frequency maxima above 1.3 kPa, and/or a high probability of being a luminal B subtype metastasized breast cancer is assigned to a sample exhibiting two frequency maxima below 1 kPa and a frequency maximum between 1.4 kPa and 2.0 kPa.
12 more elements
Method for treating breast cancer, wherein the method comprises,
- providing a tissue sample from a mammary tumour of a subject,
- assigning the tissue sample to a breast cancer subtype by determining a stiffness value for each of a plurality of points on said tissue sample using a device for determining stiffness values, resulting in a stiffness distribution, and
- assigning said sample to a breast cancer molecular subtype based on said stiffness distribution, and
- administering a treatment to the subject based on the determined breast cancer molecular subtype.
1 more element
Dependencies are inferred from the claim text.